DHR

Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis

Retrieved on: 
星期四, 五月 9, 2024
Johns Hopkins University, Traumatic brain injury, MSN, Danaher Corporation, BSN, Risk, DHR, Blood, Johns Hopkins, MD, Doctor of Philosophy, Research, TBI, Brain damage, Beacon, Patient, RN, Diagnosis, Brain, Biomarker, Emergency medicine, Medical imaging

This approach could potentially be adapted for diagnosis of other neurological conditions.

Key Points: 
  • This approach could potentially be adapted for diagnosis of other neurological conditions.
  • WASHINGTON, May 9, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator ("Danaher"), today launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI.
  • As part of the Danaher Beacons program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics, a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.
  • The Danaher Beacon for Brain Injury Diagnostics is the sixth collaboration in the Danaher Beacons program, which funds product-driven scientific research with globally recognized academic investigators.

NOW OPEN: Driscoll Children’s Hospital Rio Grande Valley

Retrieved on: 
星期三, 五月 8, 2024
Dropbox, Interview, Hospital, DHR, Robert Coronado, Bed, Health, Anesthesiology, O'Driscoll (surname), Employment, Pediatrics, Patient, Driscoll Children's Hospital, Nursing

From this moment on, children in the Rio Grande Valley with complex medical conditions will have access to care here at home, regardless of their ability to pay,” said Matt Wolthoff, President of Driscoll Children’s Hospital Rio Grande Valley.

Key Points: 
  • From this moment on, children in the Rio Grande Valley with complex medical conditions will have access to care here at home, regardless of their ability to pay,” said Matt Wolthoff, President of Driscoll Children’s Hospital Rio Grande Valley.
  • Driscoll Children’s Hospital Rio Grande Valley boasts 119 pediatric beds and more than 700 employees.
  • Driscoll Children’s Hospital Rio Grande Valley will generate $124.7 million per year in economic growth to Texas, according to a Perryman Group study commissioned by Driscoll.
  • MEDIA: Photos and video of Driscoll Children’s Hospital Rio Grande Valley can be found at this Dropbox link — including timelapse footage of its construction.

Danaher to Present at Bank of America Securities Healthcare Conference

Retrieved on: 
星期二, 五月 7, 2024
Danaher Corporation, Bank, Conference, DHR

WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT.

Key Points: 
  • WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT.
  • The event will be simultaneously webcast on www.danaher.com .

Danaher Announces Quarterly Dividend

Retrieved on: 
星期二, 五月 7, 2024
Danaher Corporation, DHR

WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 26, 2024 to holders of record on June 28, 2024.

Key Points: 

WASHINGTON, May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 26, 2024 to holders of record on June 28, 2024.

Danaher Reports First Quarter 2024 Results

Retrieved on: 
星期二, 四月 23, 2024
Cepheid variable, Webcast, Danaher Corporation, GAAP, Conference, DHR, Bank

WASHINGTON, April 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024.

Key Points: 
  • WASHINGTON, April 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024.
  • For the second quarter 2024, the Company anticipates that non-GAAP core revenue will be down mid-single digits year-over-year.
  • Danaher will discuss its first quarter results and financial guidance for the second quarter and full year 2024 during its quarterly investor conference call today starting at 8:00 a.m.
  • A replay of the conference call will be available shortly after the conclusion of the call and until May 7, 2024.

Danaher Schedules First Quarter 2024 Earnings Conference Call

Retrieved on: 
星期四, 三月 21, 2024
Webcast, Danaher Corporation, Conference, DHR

WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m.

Key Points: 
  • WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m.
  • ET and notifying the operator that you are dialing in for Danaher's earnings conference call (Conference ID: DHRQ124).
  • A replay of the conference call will be available shortly after the conclusion of the call until May 7, 2024.
  • Danaher's earnings press release, the webcast slides and other related materials will be posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings" beginning at 6:00 a.m.

Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences

Retrieved on: 
星期三, 三月 13, 2024
Health, Detection, Communication, PerkinElmer, Danaher Corporation, SAN, Leica Biosystems, University, Senior, Biology, Marketing, Molecular Devices, DHR, Pharmaceutical industry

SAN JOSE, Calif., March 13, 2024 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau's appointment as its new president, succeeding interim president, Greg Milosevich.

Key Points: 
  • , a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau's appointment as its new president, succeeding interim president, Greg Milosevich.
  • "Mary brings more than 25 years of life science experience and a track record of achieving exceptional business results to Molecular Devices," said Greg Milosevich, Vice President, and Group Executive Life Sciences Innovations Group at Danaher Corporation.
  • Prior to joining Molecular Devices, Mary spent six years at Leica Biosystems, also a Danaher operating company.
  • "In this short time as president, it's clear that Molecular Devices' innovative technology and diverse team are enabling a revolution of human health – and that's really inspiring," said Mary Duseau, President of Molecular Devices.

DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
星期一, 二月 26, 2024
Biotechnology, Telephone, News, Biophysical environment, Growth, Projection, Vaccine, COVID-19, Danaher Corporation, DHR, Research, P.C, Pharmaceutical industry

Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.
  • Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.

Danaher to Present at TD Cowen Health Care Conference

Retrieved on: 
星期二, 二月 27, 2024
Danaher Corporation, DHR, Conference

WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m.

Key Points: 
  • WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m.
  • ET.
  • The event will be simultaneously webcast on www.danaher.com .

Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets

Retrieved on: 
星期四, 二月 22, 2024
World Resources Institute, WRI, Climate, Targets, WWF, United Nations Global Compact, CDP, Health, Science Based Targets initiative, Danaher Corporation, DHR, Science, GHG, Partnership, Renewable energy

WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050.

Key Points: 
  • WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050.
  • Danaher's pledge encompasses Scope 1, 2 and 3 GHG emissions and complements its existing commitment to reduce Scope 1 and 2 GHG emissions on an absolute basis by 50.4% by 2032 compared to 2021.
  • "At the heart of everything we do at Danaher is continuous improvement, and our sustainability program further exemplifies this commitment," said Rainer M. Blair, Danaher's President and Chief Executive Officer.
  • Danaher will submit its GHG emission reduction targets to SBTi to be validated against the SBTi criteria.